MX2015016951A - Metodo de tratamiento de trastornos neurodegenerativos. - Google Patents
Metodo de tratamiento de trastornos neurodegenerativos.Info
- Publication number
- MX2015016951A MX2015016951A MX2015016951A MX2015016951A MX2015016951A MX 2015016951 A MX2015016951 A MX 2015016951A MX 2015016951 A MX2015016951 A MX 2015016951A MX 2015016951 A MX2015016951 A MX 2015016951A MX 2015016951 A MX2015016951 A MX 2015016951A
- Authority
- MX
- Mexico
- Prior art keywords
- neurodegenerative disorders
- treating neurodegenerative
- symptoms
- compound
- formula
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Dermatology (AREA)
- Steroid Compounds (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
Abstract
La presente descripción está dirigida, al menos en parte, a los tratamientos modificadores de la enfermedad para trastornos neurodegenerativos. En una modalidad, se proporciona un método para retrasar el empeoramiento de uno o más síntomas y/o la progresión de un trastorno neurodegenerativo. En una modalidad, se proporciona un método de tratamiento o mejoramiento de uno o más síntomas de un trastorno neurodegenerativo. En una modalidad, los métodos de la presente invención comprenden administrarle a un sujeto en necesidad del mismo, un compuesto que tiene la estructura de la Fórmula (la) y/o una sal farmacéuticamente aceptable del mismo. En una modalidad, el compuesto de la Fórmula (la) y/o una sal farmacéuticamente aceptable del mismo es administrado en combinación con uno o más agentes farmacológicamente activos.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361842358P | 2013-07-02 | 2013-07-02 | |
| US201461935607P | 2014-02-04 | 2014-02-04 | |
| PCT/US2014/045185 WO2015003030A1 (en) | 2013-07-02 | 2014-07-02 | Method of treating neurodegenerative disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2015016951A true MX2015016951A (es) | 2016-08-05 |
Family
ID=52144185
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015016951A MX2015016951A (es) | 2013-07-02 | 2014-07-02 | Metodo de tratamiento de trastornos neurodegenerativos. |
| MX2020004106A MX2020004106A (es) | 2013-07-02 | 2015-12-09 | Metodo de tratamiento de trastornos neurodegenerativos. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020004106A MX2020004106A (es) | 2013-07-02 | 2015-12-09 | Metodo de tratamiento de trastornos neurodegenerativos. |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20160175279A1 (es) |
| EP (2) | EP3016648A4 (es) |
| JP (3) | JP2016523927A (es) |
| KR (2) | KR20220066985A (es) |
| AU (3) | AU2014284304B2 (es) |
| BR (1) | BR112015032194A2 (es) |
| CA (1) | CA2916649A1 (es) |
| CL (1) | CL2015003668A1 (es) |
| HK (1) | HK1224220A1 (es) |
| IL (2) | IL296819A (es) |
| MX (2) | MX2015016951A (es) |
| WO (1) | WO2015003030A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015003030A1 (en) * | 2013-07-02 | 2015-01-08 | Cortice Biosciences, Inc. | Method of treating neurodegenerative disorders |
| US20180368472A1 (en) * | 2017-06-21 | 2018-12-27 | Altria Client Services Llc | Encapsulated ingredients for e-vaping devices and method of manufacturing thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1257199A (en) | 1986-05-20 | 1989-07-11 | Paul Y. Wang | Preparation containing bioactive macromolecular substance for multi-months release in vivo |
| IT1243390B (it) | 1990-11-22 | 1994-06-10 | Vectorpharma Int | Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione. |
| FR2774674B1 (fr) | 1998-02-10 | 2000-03-24 | Atochem Elf Sa | Procede de preparation d'une solution aqueuse de peroxyde d'hydrogene directement a partir d'hydrogene et d'oxygene et dispositif permettant sa mise en oeuvre |
| US5993414A (en) | 1998-04-23 | 1999-11-30 | Medtronic, Inc. | Implantable device |
| US6436091B1 (en) | 1999-11-16 | 2002-08-20 | Microsolutions, Inc. | Methods and implantable devices and systems for long term delivery of a pharmaceutical agent |
| US8138361B2 (en) | 2005-12-28 | 2012-03-20 | The Trustees Of The University Of Pennsylvania | C-10 carbamates of taxanes |
| WO2008121476A1 (en) * | 2007-03-28 | 2008-10-09 | Tapestry Pharmaceuticals, Inc. | Biologically active taxane analogs and methods of treatment by oral administration |
| WO2008109360A1 (en) * | 2007-02-28 | 2008-09-12 | Tapestry Pharmaceuticals, Inc | Taxane analogs for the treatment of brain cancer |
| US9968574B2 (en) * | 2009-05-15 | 2018-05-15 | The University Of Kentucky Research Foundation | Treatment of MCI and Alzheimer's disease |
| WO2011028571A1 (en) * | 2009-09-01 | 2011-03-10 | Tapestry Pharmaceuticals, Inc. | Taxane analogues, their use, pharmaceutical compositions containing them, and processes for their preparation |
| WO2013096870A1 (en) * | 2011-12-22 | 2013-06-27 | Knopp Neurosciences Inc | Compositions and methods for treating amyotrophic lateral sclerosis |
| WO2015003030A1 (en) * | 2013-07-02 | 2015-01-08 | Cortice Biosciences, Inc. | Method of treating neurodegenerative disorders |
-
2014
- 2014-07-02 WO PCT/US2014/045185 patent/WO2015003030A1/en active Application Filing
- 2014-07-02 JP JP2016524338A patent/JP2016523927A/ja active Pending
- 2014-07-02 BR BR112015032194A patent/BR112015032194A2/pt not_active Application Discontinuation
- 2014-07-02 EP EP14819753.6A patent/EP3016648A4/en not_active Withdrawn
- 2014-07-02 EP EP19169972.7A patent/EP3536318A1/en not_active Withdrawn
- 2014-07-02 IL IL296819A patent/IL296819A/en unknown
- 2014-07-02 IL IL242979A patent/IL242979B2/en unknown
- 2014-07-02 CA CA2916649A patent/CA2916649A1/en active Pending
- 2014-07-02 KR KR1020227015596A patent/KR20220066985A/ko not_active Application Discontinuation
- 2014-07-02 AU AU2014284304A patent/AU2014284304B2/en active Active
- 2014-07-02 MX MX2015016951A patent/MX2015016951A/es active IP Right Grant
- 2014-07-02 US US14/902,190 patent/US20160175279A1/en not_active Abandoned
- 2014-07-02 KR KR1020157037141A patent/KR20160026917A/ko not_active IP Right Cessation
-
2015
- 2015-12-09 MX MX2020004106A patent/MX2020004106A/es unknown
- 2015-12-18 CL CL2015003668A patent/CL2015003668A1/es unknown
-
2016
- 2016-11-03 HK HK16112649.2A patent/HK1224220A1/zh unknown
-
2017
- 2017-06-15 US US15/624,263 patent/US11033529B2/en active Active
-
2018
- 2018-09-28 JP JP2018183806A patent/JP2018199736A/ja active Pending
-
2019
- 2019-11-28 AU AU2019271983A patent/AU2019271983B2/en active Active
-
2021
- 2021-04-12 US US17/228,054 patent/US20210322372A1/en not_active Abandoned
- 2021-07-30 JP JP2021125152A patent/JP2021167361A/ja active Pending
-
2022
- 2022-04-06 AU AU2022202313A patent/AU2022202313A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2014284304A1 (en) | 2016-01-21 |
| AU2019271983B2 (en) | 2022-01-06 |
| AU2022202313A1 (en) | 2022-04-28 |
| WO2015003030A1 (en) | 2015-01-08 |
| HK1224220A1 (zh) | 2017-08-18 |
| IL242979A (es) | 2016-01-31 |
| AU2019271983A1 (en) | 2019-12-19 |
| IL242979B2 (en) | 2023-03-01 |
| KR20160026917A (ko) | 2016-03-09 |
| AU2014284304B2 (en) | 2019-10-03 |
| MX2020004106A (es) | 2020-07-24 |
| JP2018199736A (ja) | 2018-12-20 |
| IL296819A (en) | 2022-11-01 |
| EP3016648A4 (en) | 2017-02-22 |
| IL242979B (en) | 2022-11-01 |
| EP3016648A1 (en) | 2016-05-11 |
| US20210322372A1 (en) | 2021-10-21 |
| US11033529B2 (en) | 2021-06-15 |
| JP2016523927A (ja) | 2016-08-12 |
| US20160175279A1 (en) | 2016-06-23 |
| KR20220066985A (ko) | 2022-05-24 |
| CA2916649A1 (en) | 2015-01-08 |
| CL2015003668A1 (es) | 2016-08-12 |
| JP2021167361A (ja) | 2021-10-21 |
| US20170281592A1 (en) | 2017-10-05 |
| EP3536318A1 (en) | 2019-09-11 |
| BR112015032194A2 (pt) | 2017-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201690287A1 (ru) | 1,4-дизамещенные аналоги пиридазин хинолина и способы лечения состояний, связанных с smn-дефицитом | |
| MX2016000364A (es) | Metodos para tratar o prevenir afecciones oftalmologicas. | |
| PH12018501903A1 (en) | Methods of treating depression using orexin-2 receptor antagonists | |
| EA201592250A1 (ru) | Пиразолопирролидиновые производные и их применение в лечение заболеваний | |
| PH12014501997A1 (en) | Esketamine for the treatment of treatment-refractory or treatment-resistant depression | |
| BR112015012312A2 (pt) | método de tratamento, redução do risco, prevenção ou alívio de uma afecção ou doença pulmonar em um sujeito; método de redução ou supressão de inflamação no pulmão em um sujeito; e método de promoção de reparo pulmonar em um sujeito | |
| MX2020012924A (es) | Terapias combinadas de coenzima q10 para el tratamiento de cancer. | |
| MX2018006674A (es) | Tratamiento de cancer usando 2-desoxi-2-fluoro-l-fucosa en combinacion con un inhibidor del punto de control. | |
| NZ702730A (en) | Treatment of motor and movement disorder side effects associated with parkinson’s disease treatments | |
| EA201490254A1 (ru) | Комбинированное лечение гепатита с | |
| MX2019005779A (es) | Metodos para tratar trastornos del desarrollo y/o trastornos convulsivos con flupirtina. | |
| MX2019009292A (es) | Metodos de tratamiento de transtornos convulsivos y sindrome de prader- willi. | |
| MX2015006720A (es) | D-metadona para el tratamiento de sintomas psiquiatricos. | |
| EA201690327A1 (ru) | Терапевтические способы | |
| EP2563350A4 (en) | THERAPEUTIC REGIME AND METHOD FOR THE TREATMENT OR IMPROVEMENT OF VIEW DISORDERS ASSOCIATED WITH ENDOGENOUS RETINOID DEFICIENCY | |
| MX2020004106A (es) | Metodo de tratamiento de trastornos neurodegenerativos. | |
| MX2014014818A (es) | Composicion farmaceutica para el tratamiento de enfermedades inflamatorias de la piel. | |
| BR112015028788A2 (pt) | Peptídeos de angiotensina no tratamento da síndrome de marfan e de distúrbios relacionados | |
| MX2021014120A (es) | Tratamiento de los sintomas asociados a terapia privacion de androgenos. | |
| MY180772A (en) | Novel therapeutic mirtazapine combinations for use in pain disorders | |
| MX2014014814A (es) | Composicion farmaceutica para el tratamiento de inflamacion y dolor. | |
| MX2018001684A (es) | Metodo de curacion de heridas. | |
| MX2014014816A (es) | Composicion farmaceutica para tratar inflamacion y dolor. | |
| MX2014011922A (es) | Composicion para el tratamiento de desordenes inflamantorios e inmunes. | |
| EA201590760A1 (ru) | Применение бремеланотида в терапии женской сексуальной дисфункции |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |